Entero Health Peer Comparison
NSE: ENTERO | BSE: 544122
₹1,827.60
As on 04-Sep-2026 15:57IST
Market cap
₹7,953 Cr
Revenue (TTM)
₹7,128 Cr
P/E Ratio
63.4
P/B Ratio
4.6
Div. Yield
0 %
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
7,953 | 32 | 20 | 20 | 17 |
Revenue (₹ Cr) |
7,128 | 13 | -3 | 562 | 32 |
Net Profit (₹ Cr) |
167.66 | -1.78 | -0.07 | 1.24 | 0.84 |
Net Margin (%) |
2.35 | -8.71 | 2.62 | 0.22 | 2.62 |
RoE (%) |
7.58 | -1.56 | -0.66 | 9.81 | 17.29 |
Price to Earnings |
63.41 | -- | -- | 15.80 | 19.81 |
Price-To-Book |
4.58 | 0.29 | 2.06 | 10.37 | 3.46 |
Income Statement (₹ Cr)
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,591.21 | 12.45 | 0.83 | 0.50 | 28.66 |
|
Total Income
|
6,610.45 | 20.66 | 1.29 | 0.50 | 28.70 |
|
Total Expenditure
|
6,325.26 | 21.85 | 1.04 | 0.44 | 26.49 |
|
EBITDA
|
265.96 | -9.40 | -0.21 | 0.06 | 2.17 |
|
Depreciation
|
43.29 | 1.81 | 0.00 | 0.01 | 0.07 |
|
EBIT
|
222.66 | -11.21 | -0.21 | 0.05 | 2.10 |
|
Interest
|
54.39 | 0.02 | 0.00 | 0.01 | 0.77 |
|
Other Income
|
19.24 | 8.21 | 0.46 | 0.00 | 0.04 |
|
Exceptional Items
|
-8.18 | -- | -- | -- | -1.04 |
|
Profit before Tax
|
179.34 | -3.02 | 0.25 | 0.05 | 0.33 |
|
Provision for Tax
|
33.50 | 0.01 | -- | 0.02 | 0.16 |
|
Profit after Tax
|
145.84 | -3.04 | 0.25 | 0.03 | 0.17 |
Liabilities (₹ Cr)
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,688.61 | 111.61 | 9.46 | 0.56 | 4.70 |
|
Minority Interest
|
63.94 | -- | -- | -- | -- |
|
Non-Current Liabilities
|
206.12 | 1.14 | -- | 0.00 | 3.85 |
|
Current Liabilities
|
1,587.57 | 2.71 | 0.33 | 0.09 | 7.70 |
|
Total Liabilities
|
3,600.22 | 115.46 | 9.79 | 0.65 | 16.36 |
Assets (₹ Cr)
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,037.80 | 68.44 | 1.74 | 0.00 | 4.05 |
|
Current Assets
|
2,503.13 | 47.02 | 8.05 | 0.65 | 12.19 |
|
Total Assets
|
3,600.22 | 115.46 | 9.79 | 0.65 | 16.36 |
|
Total Debt*
|
566.68 | 0.00 | 0.00 | 0.00 | 6.89 |
|
Net Current Assets
|
915.56 | 44.31 | 7.72 | 0.56 | 4.49 |
|
Contingent Liabilities
|
5.51 | -- | 1.72 | -- | 1.79 |
Cashflow (₹ Cr)
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
96.20 | -7.02 | 0.22 | 0.19 | 3.04 |
|
Cash Flow from Investing Activities
|
-303.06 | 7.11 | -0.20 | -0.18 | 1.23 |
|
Cash from Financing Activities
|
123.66 | -- | 0.00 | -- | -4.40 |
|
Net Cash Inflow / Outflow
|
-83.20 | 0.09 | 0.01 | 0.01 | -0.12 |
Ratios
Profitability Ratios
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
ROCE (%)
|
10.93 | -2.58 | 2.66 | 9.64 | 8.25 |
|
ROE (%)
|
8.57 | -2.61 | 2.62 | 4.66 | 3.66 |
|
ROA (%)
|
4.68 | -2.52 | 2.55 | 3.22 | 0.89 |
|
EBIT Margin (%)
|
4.33 | -9.59 | 30.22 | 12.08 | 7.74 |
|
Net Margin (%)
|
2.21 | -14.70 | 19.02 | 5.07 | 0.59 |
|
Cash Profit Margin (%)
|
2.87 | -9.88 | 29.75 | 6.64 | 0.85 |
Growth Ratios
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
29.35 | -51.14 | -81.21 | -55.75 | 50.74 |
|
EBIT Growth (%)
|
35.13 | -229.03 | -71.70 | 78.70 | 487.36 |
|
Net Profit Growth (%)
|
35.75 | -431.96 | -71.86 | -15.89 | 137.55 |
|
EPS Growth (%)
|
21.32 | -431.95 | -71.86 | -15.94 | 139.47 |
|
Book Value Growth (%)
|
-2.19 | -7.97 | 2.10 | 4.77 | 3.93 |
Valuation Ratios
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Price / Earnings
|
47.12 | 0.00 | 80.86 | 275.35 | 64.91 |
|
Price / Book Value
|
3.22 | 0.26 | 2.10 | 12.53 | 2.45 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
20.43 | -23.82 | 59.92 | 115.38 | 8.11 |
|
Market Cap (₹ Cr)
|
5,420.61 | 28.93 | 19.85 | 6.99 | 11.52 |
Solvency Ratios
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.34 | 0.00 | 0.00 | 0.00 | 1.47 |
|
Short term debt to equity ratio
|
0.26 | -- | -- | -- | 0.62 |
|
Current Ratio
|
1.58 | 17.34 | 24.50 | 6.92 | 1.58 |
|
Quick Ratio
|
1.05 | 16.26 | 23.50 | 6.92 | 0.84 |
|
Interest Coverage
|
4.30 | -137.05 | 63.95 | 10.12 | 1.43 |
Operating Efficiency Ratios
| Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.39 | 55.60 | 35.52 | 57.00 | 18.89 |
|
Asset Turnover
|
2.11 | 0.10 | 0.09 | 0.63 | 1.52 |
|
Receivable days
|
56.56 | 230.34 | 482.34 | 362.19 | 90.06 |
|
Inventory Days
|
41.57 | 90.05 | 144.64 | 0.00 | 77.78 |
|
Payable days
|
34.66 | 71.74 | 44.32 | -- | 86.82 |
|
Cash Conversion Cycle
|
63.47 | 248.65 | 582.66 | -- | 81.03 |